An outbreak of "Pneumonia of Unknown Etiology" occurred in Wuhan, China, in late December 2019. Later, the agent factor was identified and coined as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease was named coronavirus disease 2019 (COVID-19). In a shorter period, this newly emergent infection brought the world to a standstill. On 11 March 2020, the WHO declared COVID-19 as a pandemic. Researchers across the globe have joined their hands to investigate SARS-CoV-2 in terms of pathogenicity, transmissibility, and deduce therapeutics to subjugate this infection. The researchers and scholars practicing different arts of medicine are on an extensive quest to come up with safer ways to curb the pathological implications of this viral infection. A huge number of clinical trials are underway from the branch of allopathy and naturopathy. Besides, a paradigm shift on cellular therapy and nano-medicine protocols has to be optimized for better clinical and functional outcomes of COVID-19-affected individuals. This article unveils a comprehensive review of the pathogenesis mode of spread, and various treatment modalities to combat COVID-19 disease.


© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Cite as

Jha, N., Jeyaraman, M., Rachamalla, M., Ojha, S., Dua, K., Chellappan, D., Muthu, S., Sharma, A., Jha, S., Jain, R., Jeyaraman, N., GS, P., Satyam, R., Khan, F., Pandey, P., Verma, N., Singh, S., Roychoudhury, S., Dolpuria, S., Ruokolainen, J. & Kesari, K. 2021, 'Current understanding of novel coronavirus: molecular pathogenesis, diagnosis, and treatment approaches', Immuno, 1(1), pp. 30-66. https://doi.org/10.3390/immuno1010004

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 14 November 2022
Was this page helpful?